When was The Alvogen founded?

The Alvogen was founded in 2009 and raised its 1st funding round 3 years after it was founded.

Where is The Alvogen located?

The Alvogen is headquartered in Morristown, United States.

How many employees does The Alvogen have?

As of Sep 30, 2026, the latest employee count at The Alvogen is 474.

Is The Alvogen a funded company?

The Alvogen is a funded company, having raised a total of $156M across 2 funding rounds to date. The company's 1st funding round was a $***** Series C round, raised on 2012.

How much is The Alvogen worth?

The last known valuation of The Alvogen was $***** as of Sep 24, 2025.

When was the latest funding round of The Alvogen?

The Alvogen's latest funding was a $***** Series D round on Jun 30, 2021, with participation from 1 investor.

Where does The Alvogen rank among its competitors?

The Alvogen ranks 6th amongst 1243 active competitors, of which 43 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was Laboratorio Reig Jofre, which secured $14.7M in May, 2025.

Who are the top competitors of The Alvogen?

The Alvogen's top competitors include Bayer, Teva Pharmaceuticals and Wockhardt. Among them, Laboratorio Reig Jofre secured the most recent funding round in May, 2025.

The Alvogen - 2026 Company Profile, Funding & Competitors

Q: Is The Alvogen an acquired company?

The Alvogen got acquired by Lotus on Sep 24, 2025.

The Alvogen is an acquired company based in Morristown (United States), founded in 2009. It operates as a Developer and marketer of pharmaceutical products. The Alvogen has raised $156M in funding from Morgan Stanley and IMM Private Equity, with last known valuation of $*****. The company has 1243 active competitors, including 43 funded and 337 that have exited. Its top competitors include companies like Bayer, Teva Pharmaceuticals and Wockhardt.

Company Details

Developer and marketer of pharmaceutical products. This company focuses on developing, in-licensing, manufacturing, and marketing pharmaceutical products. Its portfolio includes generic drugs, branded products, injectables, and complex, high-value medications such as complex inhalation therapies and strategic 505(b)(2) products. The company has a robust research and development program to support its growing pipeline. It also emphasizes ethical business practices and transparency in its interactions with healthcare providers.

Website: www.alvogen.com/
Social
Phone Number: +1 **********

Key Metrics

Founded Year

2009

Location

Morristown, United States

Stage

Acquired

Total Funding

$156M in 2 rounds

Latest Funding Round

Series D, Jun 30, 2021, $*****

Last Known Valuation

$***** as on Sep 24, 2025

Investors

Morgan Stanley & 12 more

Ranked

6^th among 1243 active competitors

Employee Count

474 as on Sep 30, 2026

Investment & Acquisitions

GRALISE & 7 more

Similar Companies

Teva Pharmaceuticals & 1462 more

Exit Details

Acquired by Lotus (Sep 24, 2025)

View The Alvogen's full profile

The Alvogen got acquired by Lotus on Sep 24, 2025 at an acquisition amount of $*****.

Click here to take a look at The Alvogen's acquisition in detail

The Alvogen has raised a total funding of $156M over 2 rounds. Its first funding round was on 2012. Its latest funding round was a Series D round on Jun 30, 2021 for $*****. 1 investor participated in its latest round. The Alvogen has 13 institutional investors.

Here is the list of recent funding rounds of The Alvogen:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 30, 2021	9473158	Series D	7162043	4734955	8363738	1999886
2012	4226	Series C	6330	7402	IMM Private Equity	2641

Access funding benchmarks and valuations. Sign up today!

View details of The Alvogen's funding rounds and investors

The Alvogen's employee count trend

The Alvogen has 474 employees as of Sep 26. Here is The Alvogen's employee count trend over the years:

Uncover The Alvogen's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of The Alvogen include Bayer, Teva Pharmaceuticals and Wockhardt. Here is the list of Top 10 competitors of The Alvogen, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Bayer 1863, Leverkusen (Germany), Public	Manufacturer of drugs	-	Digital Pharma Lab, B Capital Fund & 9 others	76/100
2nd	Teva Pharmaceuticals 1901, Petah Tikva (Israel), Public	Traditional company engaged in manufacturing generics	$500M	Berkshire Hathaway, JANA Partners & 3 others	75/100
3rd	Wockhardt 1967, Mumbai (India), Public	Manufacturer of pharmaceuticals, biotechnology products, and active pharmaceutical ingredients	-	HDFC Mutual Fund, Tata Mutual Fund & 12 others	71/100
4th	Cipla 1935, Mumbai (India), Public	Manufacturer of APIs, generic drugs, and formulation development services	-	MUFG, Eight Roads Ventures & 3 others	69/100
5th	Biological E 1953, Hyderabad (India), Funding Raised	Developer of vaccines for treating multiple diseases	-	Gates, IFC & 3 others	69/100
6th	The Alvogen 2009, Morristown (United States), Acquired	Developer and marketer of pharmaceutical products	$156M	Athyrium Capital Management, Temasek & 11 others	69/100
7th	Emcure 1981, Pune (India), Public	Developer, manufacturer, and markets a broad range of pharmaceutical products	$50M	Blackstone, Bain Capital	68/100
8th	Amneal 2002, Bridgewater (United States), Public	Manufacturer of generics formulations	-	Tarsadia, GE Capital & 2 others	68/100
9th	Laboratorio Reig Jofre 2000, Barcelona (Spain), Public	Manufacturer of pharmaceutical products and food supplements	-	CDTI, Europa	68/100
10th	Strides Pharma Science 1990, Bengaluru (India), Public	Manufacturer of generic pharmaceutical products and various specialty medical formulations	-	InvAscent, Oman India Joint Investment Fund ... & 2 others	68/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on The Alvogen's competitors? Click here to see the top ones

The Alvogen has not made any investments yet. The Alvogen has made 8 acquisitions.

Here is the list of latest three $acquisitions:

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Jan 13, 2020	Acquisition	GRALISE	2010	Lake Forest (United States)
Dec 01, 2016	Acquisition	Dolphin		Russia
Mar 07, 2016	Acquisition	County Line Pharmaceuticals	2007	Milwaukee (United States)